{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:08:08Z","timestamp":1790316488376,"version":"4.1.0"},"reference-count":41,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,4,8]],"date-time":"2007-04-08T00:00:00Z","timestamp":1175990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> The aim of this study was to investigate serum leptin, oxidized low density lipoprotein (ox\u2010LDL) and asymmetric dimethylarginine (ADMA) levels and their interaction with dyslipidaemia in adolescents with polycystic ovary syndrome (PCOS).<\/jats:p><jats:p><jats:bold>Patients and design\u2002<\/jats:bold> The study group consisted of 23 obese (obPCOS) and 21 nonobese girls with PCOS (nPCOS), and 31 lean healthy controls. PCOS was defined by the National Institutes of Health (NIH) criteria as the presence of chronic oligoanovulation and hyperandrogenism. Fasting leptin, ox\u2010LDL, ADMA and detailed lipid\u2010lipoprotein profile were determined. Atherogenic index (AI) was calculated as [Total cholesterol\u00a0\u2212\u00a0HDL cholesterol\/HDL cholesterol]. Logarithmic transformations were made for ox\u2010LDL.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Total cholesterol, triglycerides, LDL cholesterol, very low density lipoprotein (VLDL) cholesterol, apolipoprotein B, lipoprotein A levels and AI were higher and apolipoprotein AI was lower in obPCOS compared to those in controls (<jats:italic>P\u00a0&lt;<\/jats:italic>\u00a00\u00b705). LDL cholesterol, apolipoprotein B and lipoprotein A levels were higher in nPCOS compared to controls (<jats:italic>P\u00a0&lt;<\/jats:italic>\u00a00\u00b705). ADMA and ox\u2010LDL levels did not differ in the three groups. Leptin was significantly higher in obPCOS compared with that in the other two groups (<jats:italic>P\u00a0&lt;<\/jats:italic>\u00a00\u00b7001) and it was correlated with triglycerides (<jats:italic>r<\/jats:italic>\u00a0= 0\u00b762), VLDL cholesterol (<jats:italic>r<\/jats:italic>\u00a0= 0\u00b745), lipoprotein A (<jats:italic>r<\/jats:italic>\u00a0= 0\u00b738) and AI (<jats:italic>r<\/jats:italic>\u00a0= 0\u00b743) in the PCOS group (<jats:italic>P\u00a0&lt;<\/jats:italic>\u00a00\u00b705).<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> Our data demonstrate that ADMA and ox\u2010LDL levels in adolescent PCOS subjects were not different than those in controls. Abnormal lipid profile was shown in obese and nonobese girls with PCOS and leptin was related with these lipid abnormalities in the PCOS subjects.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2007.02849.x","type":"journal-article","created":{"date-parts":[[2007,5,6]],"date-time":"2007-05-06T17:58:48Z","timestamp":1178474328000},"page":"129-134","source":"Crossref","is-referenced-by-count":62,"title":["Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome"],"prefix":"10.1111","volume":"67","author":[{"given":"Fatma","family":"Demirel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysun","family":"Bideci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyami","family":"Cinaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Orhun","family":"\u00c7amurdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcrsel","family":"Bibero\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ediz","family":"Yesilkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alev","family":"Hasano\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,27]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019616-200207000-00011"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(05)70069-4"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01159.2004"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031676"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1096\/fasebj.13.10.1231","article-title":"Leptin induces oxidative stress in human endothelial cells","volume":"13","author":"Bouloum\u00e9 A.","year":"1999","journal-title":"Journal of the Federation of American Societies for Experimental Biology"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI13143"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.091561"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.20.9.2032"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.34.20963"},{"key":"e_1_2_5_11_2","first-page":"181","article-title":"The role of the monocyte in atherogenesis. I. Transition of blood\u2010borne monocytes into foam cells in fatty lesions","volume":"103","author":"Gerrity R.G.","year":"1981","journal-title":"American Journal of Pathology"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2004.03.010"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.8.3772"},{"key":"e_1_2_5_14_2","first-page":"305","article-title":"Serum hormone levels and anthropometric characteristics in girls with hyperandrogenism","volume":"41","author":"Zukauskaite S.","year":"2005","journal-title":"Medicina (Kaunas)"},{"key":"e_1_2_5_15_2","first-page":"377","volume-title":"Polycystic Ovary Syndrome","author":"Zawadzki J.K.","year":"1992"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-21-11-1440"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2006.tb02206.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low\u2010density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald W.T.","year":"1972","journal-title":"Clinical Chemistry"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.674495.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb02577.x"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(96)00531-2"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.2114\/jpa.24.511"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.4.785"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.1.141"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.1.165"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-65-3-499"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.15.7.821"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1004966"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00948-2"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(90)90177-K"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(96)06030-3"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(81)90103-9"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.9.5.579"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-3084(94)90163-5"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2004000500015"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2005.014"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(99)00401-3"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2004.11.027"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.153.1.57"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1080\/080370500439371"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200104000-00016"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2007.02849.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2007.02849.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T12:47:40Z","timestamp":1697201260000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2007.02849.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,27]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["10.1111\/j.1365-2265.2007.02849.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02849.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,27]]}}}